Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q1
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $90.21M | $72.45M | $376.13M | $106.50M | $97.29M |
| Total Operating Revenue | $90.21M | $72.45M | $376.13M | $106.50M | $97.29M |
| Cost of Revenue | $14.55M | $6.64M | $45.50M | $21.10M | $7.07M |
| Gross Profit | $75.67M | $65.80M | $330.63M | $85.40M | $90.22M |
| Operating Expense | $75.78M | $71.09M | $309.75M | $83.40M | $74.47M |
| Selling and Admin Expenses | $43.52M | $45.53M | $117.44M | $51.30M | $51.08M |
| -Selling & Marketing Expense | $28.57M | $30.32M | $6.66M | $31.30M | $34.13M |
| -General & Admin Expense | $14.95M | $15.22M | $110.78M | $20.00M | $16.95M |
| Research & Development | $32.26M | $25.56M | $100.37M | $32.10M | $23.38M |
| Operating Profit | -$111,000.00 | -$5.29M | $20.88M | $2.00M | $15.75M |
| Net Non-Operating Interest Income (Expense) | -$4.13M | $542,000.00 | -$8.74M | -$1.40M | -$7.33M |
| Non-Operating Interest Income | -$1.42M | $3.24M | $2.18M | – | $485,000.00 |
| Non-Operating Interest Expense | $2.68M | $2.70M | $10.72M | $1.40M | $7.95M |
| Other Income (Expense) | $7.28M | -$8,000.00 | $704,000.00 | $4.20M | $4.33M |
| Earnings from Equity Interest | $553,000.00 | -$385,000.00 | $623,000.00 | – | -$287,000.00 |
| Other Non-Operating Income (Expenses) | $1.42M | $377,000.00 | $1.58M | $4.20M | $71,000.00 |
| Pretax Profit | $3.04M | -$4.75M | $12.85M | $4.80M | $12.76M |
| Tax | $1.40M | $459,000.00 | $10.31M | -$500,000.00 | $5.21M |
| Net Profit | $1.64M | -$5.21M | $2.54M | $5.30M | $7.55M |
| Profit from Continuing Operations | $1.64M | -$5.21M | $2.54M | $5.30M | $7.55M |
| Minority Interests | $0.00 | $0.00 | -$313,000.00 | – | $0.00 |
| Net Income to Parent Company | $1.64M | -$5.21M | $2.85M | $5.30M | $7.55M |
| Net Income to Common Stockholders | $1.64M | -$5.21M | $2.85M | $5.30M | $7.55M |
| Basic EPS | $0.02 | -$0.07 | $0.04 | $0.08 | $0.11 |
| Diluted EPS | $0.02 | -$0.07 | $0.04 | $0.07 | $0.11 |
| Depreciation & Amortization & Depletion | – | – | $9.21M | – | – |
| -Depreciation & Amortization | – | – | $9.21M | – | – |
| Other Operating Expenses | – | – | $82.74M | – | – |
| Total Other Finance Costs | – | – | $196,000.00 | – | – |
| Gain on Sale of Security | – | – | -$4.88M | – | – |
| Special Income (Charges) | – | – | $3.39M | – | – |
| -Less:Impairment of Capital Assets | – | – | $491,000.00 | – | – |
| -Less:Other Special Charges | – | – | -$3.88M | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | $0.00 | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $467.98M | $489.37M | $499.96M | $499.96M | $473.79M |
| Total Current Assets | $280.69M | $295.51M | $299.47M | $299.47M | $277.60M |
| Cash and Cash Equivalents & Short-Term Investments | $158.28M | $170.18M | $179.10M | $179.10M | $166.17M |
| -Cash and Cash Equivalents | $158.28M | $52.38M | $145.31M | $145.31M | $132.37M |
| -Short Term Investments | $0.00 | $117.80M | $33.80M | $33.80M | $33.80M |
| Receivables | $56.98M | $60.03M | $48.44M | $48.44M | $43.61M |
| -Accounts Receivable | $56.98M | $60.03M | $41.77M | $41.77M | $43.61M |
| Inventory | $65.43M | $64.58M | $64.90M | $64.90M | $67.14M |
| Restricted Cash | $0.00 | $725,000.00 | $761,000.00 | $761,000.00 | $690,000.00 |
| Total Non-Current Assets | $187.30M | $193.85M | $200.50M | $200.50M | $196.19M |
| Net PPE | $20.48M | $23.10M | $23.97M | $23.97M | $24.99M |
| -Gross PPE | $20.48M | $23.10M | $60.40M | $60.40M | $24.99M |
| Investments and Advances | $8.58M | $8.11M | $8.65M | $8.65M | $6.67M |
| -Long Term Equity Investment | $2.06M | $1.53M | $1.94M | $1.94M | $1.01M |
| Non-Current Prepaid Assets | $92,000.00 | $93,000.00 | $94,000.00 | $94,000.00 | $95,000.00 |
| Goodwill and Other Intangible Assets | $128.08M | $130.99M | $135.54M | $135.54M | $134.93M |
| Non-Current Deferred Assets | $28.84M | $30.67M | $31.02M | $31.02M | $27.49M |
| Other Non-Current Assets | $1.23M | $894,000.00 | $1.23M | $1.23M | $2.01M |
| Total Liabilities | $197.49M | $220.41M | $222.86M | $222.86M | $209.14M |
| Total Current Liabilities | $93.25M | $112.35M | $115.79M | $115.79M | $87.91M |
| Payables | $82.32M | $103.53M | $14.59M | $14.59M | $78.22M |
| -Accounts Payable | $82.32M | $103.53M | $8.55M | $8.55M | $78.22M |
| Short-Term Debt and Capital Lease Obligation | $9.05M | $8.15M | $8.71M | $8.71M | $9.69M |
| -Current Debt | $5.47M | $5.38M | $5.34M | $5.34M | $5.21M |
| -Current Capital Lease Obligation | $3.58M | $2.77M | $3.37M | $3.37M | $4.48M |
| Current Provisions | $1.88M | $675,000.00 | $1.19M | $1.19M | – |
| Total Non-Current Liabilities | $104.25M | $108.06M | $107.07M | $107.07M | $121.23M |
| Long Term Debt and Capital Lease Obligation | $104.25M | $108.06M | $107.07M | $107.07M | $121.23M |
| -Long Term Debt | $92.40M | $93.39M | $92.72M | $92.72M | $93.14M |
| -Long Term Capital Lease Obligation | $11.85M | $14.67M | $14.35M | $14.35M | $28.09M |
| Total Equity | $270.49M | $268.96M | $277.10M | $277.10M | $264.64M |
| Stockholders' Equity | $270.49M | $268.96M | $277.10M | $277.10M | $264.64M |
| Capital Stock | $8.08M | $8.07M | $8.01M | $8.01M | $7.95M |
| -Common Stock | $8.08M | $8.07M | $8.01M | $8.01M | $7.95M |
| Additional Paid-In Capital | $520.31M | $518.60M | $513.26M | $513.26M | $507.72M |
| Retained Earnings | -$278.25M | -$281.46M | -$272.98M | -$272.98M | -$276.88M |
| Gains/Losses Not Affecting Retained Earnings | $20.34M | $23.75M | $28.82M | $28.82M | $25.85M |
| Other Non-Current Liabilities | – | -$1,000.00 | – | – | -$1,000.00 |
| Minority Interests | – | $0.00 | $0.00 | $0.00 | – |
| -Taxes Receivable | – | – | $4.74M | $4.74M | – |
| -Other Receivables | – | – | $1.93M | $1.93M | – |
| Prepaid Assets | – | – | $6.26M | $6.26M | – |
| Other Current Assets | – | – | $1,000.00 | $1,000.00 | – |
| -Accumulated Depreciation | – | – | -$36.43M | -$36.43M | – |
| -Goodwill | – | – | $3.32M | $3.32M | – |
| -Other Intangible Assets | – | – | $132.22M | $132.22M | – |
| -Total Tax Payable | – | – | $6.04M | $6.04M | – |
| Current Accrued Expenses | – | – | $91.31M | $91.31M | – |
| Other Current Liabilities | – | – | -$1,000.00 | -$1,000.00 | -$1,000.00 |
| -Available for Sale Securities | – | – | – | – | $1.39M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$9.66M | $1.95M | $54.71M | $10.71M | $32.03M |
| Net cash flow from continuing operations | -$9.66M | $1.95M | $54.71M | $10.71M | $32.03M |
| Net Income from Continuing Operations | $3.04M | -$4.75M | $12.85M | $4.80M | $12.76M |
| Gain/Loss from Continuing Operations | -$521,000.00 | $391,000.00 | -$4.36M | -$4.63M | $288,000.00 |
| Depreciation & Depletion & Amortization | $3.04M | $3.12M | $11.22M | $3.21M | $2.73M |
| Other Non-Cash Items | -$1.18M | -$567,000.00 | $13.38M | $2.29M | $2.70M |
| Change in Working Capital | -$18.14M | $445,000.00 | $10.39M | -$685,000.00 | $14.78M |
| -Change in Receivables | $5.72M | -$4.40M | -$3.36M | -$14.81M | $9.09M |
| -Change in Inventory | -$6.99M | -$264,000.00 | -$1.29M | $2.22M | $548,000.00 |
| -Change in Payables and Accrued Expense | -$18.44M | $5.29M | $14.13M | $9.99M | $3.11M |
| -Change In Other Working Capital | $1.58M | -$181,000.00 | $902,000.00 | $1.92M | $2.03M |
| Net cash flow from investing | -$83,000.00 | -$84.76M | $26.25M | -$45,000.00 | -$349,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$83,000.00 | -$84.76M | $26.25M | -$44,000.00 | -$349,000.00 |
| Capital Expenditure | -$83,000.00 | -$238,000.00 | -$749,000.00 | -$269,000.00 | -$70,000.00 |
| Net Intangibles Purchase and Sale | $0.00 | $0.00 | -$6,000.00 | $0.00 | $0.00 |
| Net Business Purchase and Sale | $0.00 | $0.00 | -$58.22M | -$8,000.00 | -$302,000.00 |
| Net Investment Purchase and Sale | $0.00 | -$84.52M | $85.22M | $233,000.00 | $23,000.00 |
| Financing Cash Flow | -$2.45M | -$9.22M | $1.50M | $1.04M | $9.93M |
| Net Cash Flow from Continuing Financing Activities | -$2.45M | -$9.22M | $1.50M | $1.04M | $9.93M |
| Net Issuance Payments Of Debt | -$919,000.00 | -$12.98M | -$4.25M | -$1.37M | -$1.10M |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $1.22M | $3.88M | $19.81M | $5.25M | $13.28M |
| Ending Cash Balance | $158.28M | $52.38M | $145.31M | $145.31M | $132.37M |
| Net Change in Cash | -$12.19M | -$92.03M | $82.45M | $11.70M | $41.61M |
| Beginning Cash Balance | $52.38M | $145.31M | $54.94M | $132.37M | $92.09M |
| Effect of Exchange Rate Changes | $292,000.00 | -$895,000.00 | $7.91M | $1.24M | -$1.33M |
| Free Cash Flow | -$9.74M | $1.71M | $53.95M | $10.44M | $31.96M |
| Net Other Investing Changes | – | – | -$1,000.00 | – | – |
| Net Other Financing Charges | – | – | -$7.88M | $0.00 | -$1.91M |
No comments yet — be the first to weigh in on PHAR.